Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Wenhao Xu, Aihetaimujiang Anwaier, Chunguang Ma, Wangrui Liu, Xi Tian, Maierdan Palihati, Xiaoxin Hu, Yuanyuan Qu, Hailiang Zhang & Dingwei Ye. (2021) Multi-omics reveals novel prognostic implication of SRC protein expression in bladder cancer and its correlation with immunotherapy response. Annals of Medicine 53:1, pages 596-610.
Read now
Read now
Articles from other publishers (23)
Sneha Sree Mullapudi, Juwita Norasmara Rahmat, Ratha Mahendran, Yew Koon Lim, Lee Ting Ong, Kah Ying Wong, Edmund Chiong, En-Tang Kang & Koon Gee Neoh. (2022) Tumor-targeting albumin nanoparticles as an efficacious drug delivery system and potential diagnostic tool in non-muscle-invasive bladder cancer therapy. Nanomedicine: Nanotechnology, Biology and Medicine 46, pages 102600.
Crossref
Crossref
Kit Man Chan, Jonathan Gleadle, Jordan Li, Krasimir Vasilev & Melanie MacGregor. (2020) Shedding Light on Bladder Cancer Diagnosis in Urine. Diagnostics 10:6, pages 383.
Crossref
Crossref
Ashish Gupta, Navneeta Bansal, Nilay Mitash, Deepak Kumar, Manoj Kumar, Satya Narain Sankhwar, Anil Mandhani & Uday Pratap Singh. (2020) NMR-derived targeted serum metabolic biomarkers appraisal of bladder cancer: A pre- and post-operative evaluation. Journal of Pharmaceutical and Biomedical Analysis 183, pages 113134.
Crossref
Crossref
Haleem J. Issaq & Timothy D. Veenstra. 2020. Proteomic and Metabolomic Approaches to Biomarker Discovery. Proteomic and Metabolomic Approaches to Biomarker Discovery
1
16
.
Guangguo Tan, Haibo Wang, Jianlin Yuan, Weijun Qin, Xin Dong, Hong Wu & Ping Meng. (2017) Three serum metabolite signatures for diagnosing low-grade and high-grade bladder cancer. Scientific Reports 7:1.
Crossref
Crossref
Kewal K. JainKewal K. Jain. 2017. The Handbook of Biomarkers. The Handbook of Biomarkers
273
462
.
Elin H. Richardsen & Lill-Tove Busund. 2015. Pelvic Cancer Surgery. Pelvic Cancer Surgery
79
91
.
Sheng-Fang Su, André Luís de Castro Abreu, Yoshitomo Chihara, Yvonne Tsai, Claudia Andreu-Vieyra, Siamak Daneshmand, Eila C. Skinner, Peter A. Jones, Kimberly D. Siegmund & Gangning Liang. (2014) A Panel of Three Markers Hyper- and Hypomethylated in Urine Sediments Accurately Predicts Bladder Cancer Recurrence. Clinical Cancer Research 20:7, pages 1978-1989.
Crossref
Crossref
Kewal K. JainKewal K. Jain. 2014. Applications of Biotechnology in Oncology. Applications of Biotechnology in Oncology
87
248
.
Navneeta Bansal, Ashish Gupta, Nilay Mitash, Prashant Singh Shakya, Anil Mandhani, Abbas Ali Mahdi, Satya Narain Sankhwar & Sudhir Kumar Mandal. (2013) Low- and High-Grade Bladder Cancer Determination via Human Serum-Based Metabolomics Approach. Journal of Proteome Research 12:12, pages 5839-5850.
Crossref
Crossref
M. Böhm, F. vom Dorp, M. Schostak & O.W. Hakenberg. (2013) Urinzytologie – Update 2013Urine cytology – update 2013. Der Urologe 52:9, pages 1207-1224.
Crossref
Crossref
Hung-Lung Ke, Meng Chen, Yuanqing Ye, Michelle A.T. Hildebrandt, Wen-Jeng Wu, Hua Wei, Maosheng Huang, David W. Chang, Colin P. Dinney & Xifeng Wu. (2013) Genetic variations in micro-RNA biogenesis genes and clinical outcomes in non-muscle-invasive bladder cancer. Carcinogenesis 34:5, pages 1006-1011.
Crossref
Crossref
Ting Lei, Xuhong Zhao, Sheng Jin, Qian Meng, Hui Zhou & Man Zhang. (2013) Discovery of Potential Bladder Cancer Biomarkers by Comparative Urine Proteomics and Analysis. Clinical Genitourinary Cancer 11:1, pages 56-62.
Crossref
Crossref
Haleem J. Issaq & Timothy D. Veenstra. 2013. Proteomic and Metabolomic Approaches to Biomarker Discovery. Proteomic and Metabolomic Approaches to Biomarker Discovery
1
16
.
Jian Zhang, Siwei Wei, Lingyan Liu, G.A. Nagana Gowda, Patty Bonney, Jane Stewart, Deborah W. Knapp & Daniel Raftery. (2012) NMR-based metabolomics study of canine bladder cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1822:11, pages 1807-1814.
Crossref
Crossref
Maria Frantzi, Manousos Makridakis & Antonia Vlahou. (2012) Biomarkers for bladder cancer aggressiveness. Current Opinion in Urology 22:5, pages 390-396.
Crossref
Crossref
David W. Chang, Jian Gu & Xifeng Wu. (2012) Germline prognostic markers for urinary bladder cancer: Obstacles and opportunities. Urologic Oncology: Seminars and Original Investigations 30:4, pages 524-532.
Crossref
Crossref
Han Han, Erika M. Wolff & Gangning Liang. (2012) Epigenetic Alterations in Bladder Cancer and Their Potential Clinical Implications. Advances in Urology 2012, pages 1-11.
Crossref
Crossref
Marcus Horstmann. (2011) Currently Available Urine-Based Tumour Markers in the Detection of New and Recurrent Urothelial Bladder Cancer. Nephro-Urology Monthly 4:1, pages 345-349.
Crossref
Crossref
Richard T. Bryan, Wenbin Wei, Neil J. Shimwell, Stuart I. Collins, Syed A. Hussain, Lucinda J. Billingham, Paul G. Murray, Nayneeta Deshmukh, Nicholas D. James, D. Michael A. Wallace, Philip J. Johnson, Maurice P. Zeegers, K. K. Cheng, Ashley Martin & Douglas G. Ward. (2011) Assessment of high-throughput high-resolution MALDI-TOF-MS of urinary peptides for the detection of muscle-invasive bladder cancer. PROTEOMICS - Clinical Applications 5:9-10, pages 493-503.
Crossref
Crossref
Yuanbin Ru, Garrett M. Dancik & Dan Theodorescu. (2011) Biomarkers for prognosis and treatment selection in advanced bladder cancer patients. Current Opinion in Urology 21:5, pages 420-427.
Crossref
Crossref
Haleem J. Issaq, Timothy J. Waybright & Timothy D. Veenstra. (2011) Cancer biomarker discovery: Opportunities and pitfalls in analytical methods. ELECTROPHORESIS 32:9, pages 967-975.
Crossref
Crossref
Que N. Van, Timothy D. Veenstra & Haleem J. Issaq. (2010) Metabolic Profiling for the Detection of Bladder Cancer. Current Urology Reports 12:1, pages 34-40.
Crossref
Crossref